Surgical and hybrid atrial fibrillation ablation procedures.

Hybrid ablation for atrial fibrillation: a systematic review. J Interv Card Electrophysiol (2016) 0.80

Hybrid approaches in atrial fibrillation ablation: why, where and who? J Thorac Dis (2015) 0.76

Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation. J Atr Fibrillation (2015) 0.75

Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction. J Atr Fibrillation (2014) 0.75

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J (2015) 3.70

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol (2003) 3.55

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature (2007) 3.46

The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project. Pacing Clin Electrophysiol (2011) 2.99

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA (2013) 2.88

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation (2003) 2.68

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace (2015) 2.66

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52

How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey. Europace (2014) 2.01

[Takotsubo and surroundings. Step by step postpartum stress-induced cardiomyopathy shows its facet. A peculiar case of atypical takotasubo in the peripartum period]. G Ital Cardiol (Rome) (2014) 2.00

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol (2012) 1.95

Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace (2009) 1.93

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J (2009) 1.89

Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol (2013) 1.84

Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace (2004) 1.66

Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk? Am Heart J (2006) 1.63

The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet (2007) 1.61

In vitro comparison of platinum-iridium and gold tip electrodes: lesion depth in 4 mm, 8 mm, and irrigated-tip radiofrequency ablation catheters. Europace (2009) 1.61

Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol (2006) 1.60

The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol (2008) 1.60

Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients. J Cardiovasc Electrophysiol (2011) 1.55

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol (2011) 1.54

Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators. Europace (2012) 1.52

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49

Recurrent vasovagal syncope: comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing. Eur Heart J (2009) 1.48

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46

Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45. J Mol Cell Cardiol (2006) 1.45

Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace (2009) 1.44

Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation. Europace (2013) 1.41

Common trunk of the right and left inferior pulmonary veins: previously unreported anatomic variant with implications for catheter ablation. Heart Rhythm (2007) 1.41

The role of premature atrial contractions as the main triggers of postoperative atrial fibrillation. J Electrocardiol (2005) 1.40

2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Rev Esp Cardiol (Engl Ed) (2016) 1.39

Three-dimensional guided renal denervation to treat drug-resistant arterial hypertension in a patient with renal insufficiency. Hypertension (2012) 1.39

Identification of "substrate fibrillators" and "trigger fibrillators" by pacemaker diagnostics. Heart Rhythm (2006) 1.38

Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol (2009) 1.35

Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Mol Biol Cell (2004) 1.31

Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol (2012) 1.26

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart (2011) 1.22

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J (2013) 1.17

Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proc Natl Acad Sci U S A (2006) 1.17

Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol (2011) 1.16

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16

Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am J Physiol Heart Circ Physiol (2002) 1.15

:Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. Int J Cardiol (2008) 1.15

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13

Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J (2010) 1.10

Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol (2002) 1.09

[Takotsubo or peripartum cardiomyopathy? A challenging clinical dilemma]. G Ital Cardiol (Rome) (2014) 1.05

Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. J Thorac Cardiovasc Surg (2009) 1.04

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J (2009) 1.02

ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Europace (2012) 1.01

Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol (2011) 1.01

Characterization of a new pulmonary vein variant using magnetic resonance angiography: incidence, imaging, and interventional implications of the "right top pulmonary vein". J Cardiovasc Electrophysiol (2004) 1.00

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation (2011) 0.99

Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography. Eur J Echocardiogr (2009) 0.98

Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey. Europace (2012) 0.98

Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. J Interv Card Electrophysiol (2010) 0.97

Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res (2007) 0.95

Echocardiographic assessment of left ventricular mass in neonatal and adult mice: accuracy of different echocardiographic methods. Echocardiography (2006) 0.95

Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography (2007) 0.95

EnSite Velocity cardiac mapping system: a new platform for 3D mapping of cardiac arrhythmias. Expert Rev Med Devices (2010) 0.95

Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace (2012) 0.94

Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. Europace (2013) 0.94

Long-term effects of the maze procedure on atrial size and mechanical function. Ann Thorac Surg (2008) 0.93

Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace (2013) 0.92

Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. Am J Cardiol (2012) 0.91

New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation (2006) 0.91

Hypertension and cardiac arrhythmias. Curr Pharm Des (2007) 0.91

Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace (2010) 0.91

How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Europace (2012) 0.90

Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study. Europace (2013) 0.90

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail (2011) 0.90

Acute and clinical effects of cryoballoon pulmonary vein isolation in patients with symptomatic paroxysmal and persistent atrial fibrillation. Europace (2008) 0.90

Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol (2008) 0.90

Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey. Europace (2014) 0.90

Electrical storm originating from a left ventricular epicardial scar in a patient with completely normal endocardial voltage. Heart Vessels (2011) 0.89

Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace (2013) 0.89

Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace (2010) 0.88

Uncommon cause of ST-segment elevation in V1-V3: incremental value of cardiac magnetic resonance imaging. Clin Res Cardiol (2014) 0.88

Chloroquine cardiomyopathy - a review of the literature. Immunopharmacol Immunotoxicol (2013) 0.88

Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes (2012) 0.87

Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol (2009) 0.86

Replacement of connexin43 by connexin26 in transgenic mice leads to dysfunctional reproductive organs and slowed ventricular conduction in the heart. BMC Dev Biol (2007) 0.86

Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace (2015) 0.86

Transcatheter aortic valve implantation for degenerative aortic valve regurgitation long after heart transplantation. Ann Thorac Surg (2013) 0.86

Predictive value of electrocardiogram in diagnosing acute coronary artery lesions among patients with out-of-hospital-cardiac-arrest. Resuscitation (2013) 0.85

Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. Europace (2012) 0.85